Intravitreal aflibercept for polypoidal choroidal vasculopathy after developing ranibizumab tachyphylaxis

PURPOSE: To evaluate the effect of aflibercept treatment after developing ranibizumab tachyphylaxis for the treatment of polypoidal choroidal vasculopathy (PCV). PATIENTS AND METHODS: Ten eyes from ten patients with PCV who developed ranibizumab tachyphylaxis were reviewed. Tachyphylaxis was defined...

Descripción completa

Detalles Bibliográficos
Autores principales: Miura, Masahiro, Iwasaki, Takuya, Goto, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3743523/
https://www.ncbi.nlm.nih.gov/pubmed/23966764
http://dx.doi.org/10.2147/OPTH.S50634

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3743523/
https://www.ncbi.nlm.nih.gov/pubmed/23966764
http://dx.doi.org/10.2147/OPTH.S50634

Ejemplares similares